Tarik Hadid is an Oncology physician affiliated with Wayne State University. OpenAlex indexes 77 publications with 598 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11900 E 12 Mile Rd Ste 308
Warren, MI 480933491
Telephone
586-574-5080Registry record last updated 27 Jun 2019.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20253 payments
- Agios Pharmaceuticals, Inc.Program year20251 payment
- GlaxoSmithKline, LLC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
27.6%Phenothiazine8.9%Prochlorperazine Maleate100%Part D≥16 patientsAtypical Antipsychotic7.4%Olanzapine Odt100%Part D≥11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
21.7%Serotonin-3 Receptor Antagonist8.4%Ondansetron Odt100%Part D≥15 patientsCorticosteroid6.9%Prednisone100%Part D<11 patients+ 1 more class in this area
Respiratory
10.8%Opioid Agonist10.8%Hydrocodone-Acetaminophen100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluating artificial intelligence (AI) as a clinical decision support tool for lung cancer treatment recommendations.
Journal of Clinical Oncology
2025 - Racial and socioeconomic disparities in survival among patients with metastatic non–small cell lung cancer
JNCI Journal of the National Cancer Institute
2024 - Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitors
Therapeutic Advances in Vaccines and Immunotherapy
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Pranatharthi Chandrasekar, MD
Wayne State University
Gerold Bepler, MD
Wayne State University
Eishi Asano, MD
Wayne State University
Bret Hughes, MD
Wayne State University
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”